ClinicalTrials.govpublic full text
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
lung cancer, non-small cell, egfr gene mutation, egfr-tki resistant mutation, primary resistance, circulating tumor dna
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 474773
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.